Showing results (91-100 of 111) with videos related to
Sort By:
Pageof 12
Stem Cells Translational Medicine|November 6, 2018
Mesenchymal Stem Cells and Induced Bone Marrow-Derived Macrophages Synergistically Improve Liver Fibrosis in MiceYusuke Watanabe, Atsunori Tsuchiya, Satoshi Seino, et al.Internal Medicine (Tokyo, Japan)|March 25, 2025
Coexistence of Relapsing Polychondritis, Crohn's Disease, and Pyoderma Gangrenosum Treated Successfully with Adalimumab: A Case Report and Literature ReviewShun Yamazaki, Kentaro Tominaga, Kotaro Watanabe, et al.Digestive Diseases and Sciences|November 13, 2023
Red Dichromatic Imaging Improves the Recognition of Bleeding Points During Endoscopic Submucosal DissectionYosuke Mori, Taro Iwatsubo, Akitoshi Hakoda, et al.JGH Open : an Open Access Journal of Gastroenterology and Hepatology|June 26, 2023
Machine learning prediction model for treatment responders in patients with primary biliary cholangitisNaruhiro Kimura, Kazuya Takahashi, Toru Setsu, et al.Journal of Gastroenterology and Hepatology|September 3, 2017
Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitorToshihisa Takeuchi, Yoshiaki Takahashi, Shinpei Kawaguchi, et al.Journal of Clinical Biochemistry and Nutrition|April 4, 2018
Effect of egualen sodium hydrate on small-intestinal mucosal damage induced by low-dose aspirin: a prospective randomized clinical trialMunetaka Iguchi, Kazuki Kakimoto, Takanori Kuramoto, et al.Journal of Clinical Biochemistry and Nutrition|November 30, 2018
Dual antiplatelet therapy does not affect the incidence of low-dose aspirin-induced small intestinal mucosal injury in patients after percutaneous coronary intervention for coronary stenosis: a multicenter cross-sectional studyAzusa Hara, Kazuhiro Ota, Toshihisa Takeuchi, et al.Digestion|January 17, 2023
Examination on Factors Affecting Symptom Change after Drug Withdrawal in Patients with Mild Erosive Gastroesophageal Reflux Disease Undergoing Symptom-Controlled Maintenance Therapy with Acid-Secretion Inhibition DrugsHironori Tanaka, Toshihisa Takeuchi, Shinya Nishida, et al.Digestion|June 15, 2022
Risk Factors for Nephrotoxicity due to Tacrolimus Therapy for Ulcerative ColitisSatoshi Nakata, Kazuki Kakimoto, Keijiro Numa, et al.Oncotarget|May 19, 2018
Clinical outcome of hepatocellular carcinoma can be predicted by the expression of hepatic progenitor cell markers and serum tumour markersSatoshi Seino, Atsunori Tsuchiya, Yusuke Watanabe, et al.Pageof 12